| [1] |
ZHANG Bolun, WANG Jia, ZHU Jiahe, XING Dehao, DING Gaoheng, LIU Yuqin.
Trends in incidence and mortality of prostate cancer in Gansu Pro-vince from 2010 to 2021 and its predictive analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 562-567.
|
| [2] |
YU Miaomiao, ZHANG Chunyan, YUAN Rongtao, GUAN Zhihui, GONG Luyang, WANG Qimin, CHEN Hang, GUO Qingyuan, WANG Lili, ZHOU Jianhua.
Impact of C. leadbetteri on the proliferation,invasion and migration of Cal27 tongue squamous cell carcinoma cell line
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 613-618.
|
| [3] |
LIANG Zhuowei, DU Youqin, YAN Chang, YANG Xiaohui, HUANG Shiting, QU Song.
Comparative efficacy and safety of TPF versus GP induction chemotherapy combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 366-371.
|
| [4] |
ZHANG Qiqi, SUN Na, BAI Yunfei.
USP41 modulates the malignant biological behaviors of head and neck squamous cell carcinoma through the deubiquitination of STAT1#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 383-390.
|
| [5] |
WANG Shenghui, ZHANG Zongnai , JIA Zhichao, ZHENG Bin, LI Xiaoyu , GAO Yuan , ZHOU Mai.
CRS combined with HIPEC for peritoneal metastasis in colorectal cancer: correlation between primary tumor location and clinical outcomes
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 195-200.
|
| [6] |
SUN Ting, LIU Jiahuan, CAI Lina, ZHENG Hengyu, YE Xianghong.
Best evidence of preoperative nutritional intervention in neoadjuvant chemotherapy for gastric cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 207-.
|
| [7] |
WU Xinyu , DAI Hanjue , JIANG Hua.
Exploring the mechanisms of gastric cancer development and therapeutic strategies from an evolutionary perspective
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 230-236.
|
| [8] |
DENG Yue, ZHAO Yue, ZHANG Shichuan.
Research progress of hypofractionated radiotherapy combined with immunotherapy in head and neck squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 244-250.
|
| [9] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
| [10] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
| [11] |
ZHANG Yuanfen, LONG Ying, YAO Desheng.
Relationship between perineural invasion,clinical pathological characteristics of cervical cancer and its effects on prognosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 109-114.
|
| [12] |
AN Yanxiao, JIAO Hanliang, QI Yanwei, ZHONG Zhiyong.
Effects of lncRNA PSMA3-AS1 on proliferation,migration and invasion of neuroblastoma cells by regulating the miR-186?5p/SOX4 axis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 715-721.
|
| [13] |
FANG Liaoxin, KANG Xiaofeng, XUE Chunyuan, PAN Lu, CHEN Jiaxin, TANG Chuanhao, SUN Liying, XU Xiaojie, DU Yimeng .
Effects of Omicron variant XBB.. spike protein on biological function of human non-small cell lung cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 271-276.
|
| [14] |
CHEN Kun, YANG Hui, LIU Zijia, ZHANG Xiaolin, XU Zhuoyi, LIU Bing, ZHAO Yubao, DING Lu, DENG Yang.
Expression of HLA-DRA protein in hepatocellular carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 84-89.
|
| [15] |
WEI Xiaohuan, SHAN Qianqian, LIU Yuanyuan.
Galectin-4 regulates PD-L1 and affects the function of CD8+T cells in killing liver cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 532-537.
|